Sotabase

Career

· Professor, Cornell University2013–
· Professor, Humboldt-Universität zu Berlin2009–2013
· Professor, University of Freiburg2001–2009
· Associate Professor, University of Dortmund1999–2001
· Research Assistant, Max Planck Institute for Informatics1993–1999
· Doctoral Candidate, Saarland University1990–1993
· Graduate Student, University of Osnabrück1984–1990

Publications (754)

Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.
New England Journal of Medicine · 2015
4,617
cited
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
New England Journal of Medicine · 2018
3,915
cited
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials
The Lancet · 2004
2,653
cited
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
The Lancet · 2010
2,132
cited
Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the
Stroke · 2006
1,545
cited
Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke: A Consensus Statement
Stroke · 2013
1,442
cited
Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study
Annals of Neurology · 2006
1,307
cited
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Journal of the American Medical Association (JAMA) · 1999
1,211
cited
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
New England Journal of Medicine · 2001
1,136
cited
Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial
The Lancet · 2012
1,123
cited
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase
Stroke · 2005
1,100
cited
Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial
The Lancet · 1996
1,080
cited
Closure or medical therapy for cryptogenic stroke with patent foramen ovale.
New England Journal of Medicine · 2012
1,011
cited
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
New England Journal of Medicine · 2008
848
cited
Transient ischemic attack--proposal for a new definition.
New England Journal of Medicine · 2002
844
cited
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest · 2008
798
cited
Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
Journal of the American Medical Association (JAMA) · 2000
756
cited
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study
Lancet Neurology · 2012
747
cited
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.
Journal of the American Medical Association (JAMA) · 2005
729
cited
Telmisartan to prevent recurrent stroke and cardiovascular events.
New England Journal of Medicine · 2008
688
cited
Sotabase